Exercise shows large effects on depressive symptoms

Whether exercise genuinely works as a treatment for depression, rather than merely lifting mood in the moment, has been debated for years. Individual trials have often been small and their methods varied, so the overall size of the effect and the conditions under which exercise works best have remained uncertain. This review set out to estimate how effective exercise is for depressive symptoms compared with non-active control groups, to identify what moderates that effect, and to check for publication bias. Getting a reliable answer matters because exercise is cheap, widely accessible and carries broad health benefits beyond mental health.

The researchers systematically searched eight databases, including Cochrane, PubMed, MEDLINE, Embase, SPORTDiscus, PsycINFO, Scopus and Web of Science, from inception to 13 September 2022, without language restrictions. They included randomised controlled trials of adults aged 18 or older who either had a diagnosis of major depressive disorder or scored above threshold on validated depression screening measures. Eligible interventions were aerobic and/or resistance exercise compared with a non-exercising control group. Forty-one studies comprising 2,264 participants post-intervention were pooled in the meta-analysis, with meta-regression used to explore moderators.

Exercise produced a large overall effect on depressive symptoms, with a standardised mean difference of -0.946 (95% CI -1.18 to -0.71), corresponding to a number needed to treat of 2. Effects were large in the 20 studies of people with diagnosed major depressive disorder (SMD -0.998) and in the 40 studies using supervised exercise (SMD -1.026). When the analysis was restricted to the 12 studies at low risk of bias, the effect was moderate rather than large (SMD -0.666, NNT 2.8), which suggests some inflation from weaker trials.

This adds substantial weight to the case that exercise is an efficacious, evidence-based option for depression, not just a general wellbeing booster. The authors conclude it should be offered as a treatment option, particularly supervised and group formats using moderate-intensity aerobic exercise. At the same time, the review is honest about the limits: many included trials had small samples and methods varied considerably between studies. Open questions remain about optimal dose, intensity and duration, and how exercise compares with or combines with established treatments such as therapy and medication.

For anyone dealing with low mood or depressive symptoms, this is strong evidence that regular exercise can meaningfully help, and the effect sizes here are large rather than marginal. The finding that supervised and group exercise showed particularly large effects is a reason to think structure and accountability may matter, not just the movement itself. It is worth remembering that the most rigorous trials showed a moderate rather than large effect, so exercise is not a guaranteed fix. This is information about what the evidence shows, not a substitute for professional care for anyone struggling with depression.